A PHASE II STUDY OF S-1 IN PATIENTS (PTS) WITH CYTOKINE-REFRACTORY METASTATIC RENAL CELL CANCER (MRCC)

被引：0
|
作者：
Naito, S. [1 ]
Akaza, H. [2 ]
Usami, M. [3 ]
Tsukamoto, T. [4 ]
Shinohara, N. [5 ]
Tomita, Y. [6 ]
Namiki, M. [7 ]
机构：
[1] Kyushu Univ Hosp, Fukuoka 812, Japan
[2] Tsukuba Univ Hosp, Tsukuba, Ibaraki, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[4] Sapporo Med Univ, Sapporo, Hokkaido, Japan
[5] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
[6] Yamagata Univ, Sch Med, Yamagata 99023, Japan
[7] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] A phase II study of S-1 for the treatment of cytokine-refractory metastatic renal cell carcinoma
    Naito, S.
    Eto, M.
    Shinohara, N.
    Tomita, Y.
    Fujisawa, M.
    Namiki, M.
    Nishikido, M.
    Usami, M.
    Tsukamoto, T.
    Akaza, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Final Results of a Phase II Study of S-1 in Patients with Cytokine-refractory Metastatic Renal Cell Carcinoma
    Naito, Seiji
    Tatsugami, Katsunori
    Shinohara, Nobuo
    Tomita, Yoshihiko
    Mizokami, Atsushi
    Fujisawa, Masato
    Hashine, Katsuyoshi
    Nishikido, Masaharu
    Nakagawa, Masayuki
    Tsukamoto, Taiji
    Akaza, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (02) : 122 - 126
  • [3] Multicenter Phase II Trial of S-1 in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Naito, Seiji
    Eto, Masatoshi
    Shinohara, Nobuo
    Tomita, Yoshihiko
    Fujisawa, Masato
    Namiki, Mikio
    Nishikido, Masaharu
    Usami, Michiyuki
    Tsukamoto, Taiji
    Akaza, Hideyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5022 - 5029
  • [4] An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma
    Seiji Naito
    Taiji Tsukamoto
    Michiyuki Usami
    Hiroyuki Fujimoto
    Hideyuki Akaza
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 1065 - 1070
  • [5] An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma
    Naito, Seiji
    Tsukamoto, Taiji
    Usami, Michiyuki
    Fujimoto, Hiroyuki
    Akaza, Hideyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1065 - 1070
  • [6] Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
    Rixe, Olivier
    Bukowski, Ronald M.
    Michaelson, M. Dror
    Wilding, George
    Hudes, Gaty R.
    Bolte, Oliver
    Motzer, Robert J.
    Bycott, Paul
    Liou, Katherine F.
    Freddo, James
    Trask, Peter C.
    Kim, Sinil
    Rini, Brian I.
    LANCET ONCOLOGY, 2007, 8 (11): : 975 - 984
  • [7] A phase II study of sunitinib administered in a continuous daily regimen in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC).
    De Mulder, P. H.
    Roigas, J.
    Gillessen, S.
    Srinivas, S.
    Pisa, P.
    Vogelzang, N.
    Fountzilas, G.
    Peschel, C.
    Baum, C.
    Escudier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 223S - 223S
  • [8] Continuous daily administration of sunitinib malate (SU11248) - A phase II study in patients (PTS) with cytokine-refractory metastatic renal cell carcinoma (MRCC)
    Escudier, Bernard
    Roigas, Jan
    Gillessen, Silke
    Srinivas, Sandhya
    Pisa, Pavel
    Vogelzang, Nicholas
    Fountzilas, George
    Peschel, Christian
    Baum, Charles M.
    De Mulder, Pieter
    ANNALS OF ONCOLOGY, 2006, 17 : 144 - 144
  • [9] A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) - final results
    Escudier, B.
    Srinivas, S.
    Roigas, J.
    Gillessen, S.
    Harmenberg, U.
    De Mulder, P. H.
    Fountzilas, G.
    Vogelzang, N.
    Peschel, C.
    Flodgren, P.
    EJC SUPPLEMENTS, 2007, 5 (04): : 299 - 300
  • [10] Phase II study of lenalidomide in patients (pts) with metastatic renal cell cancer (MRCC).
    Marsh, L.
    Khan, M.
    Needle, M.
    Amato, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
12345